drugset / Trial / NCT02066298

Steroids In Eosinophil Negative Asthma

NCT02066298

RandomizedCrossoverQuadruple-blindTreatment

Summary

Because approximately half of all mild-moderately-severe asthma is persistently non-eosinophilic, it is important to determine prospectively if patients who are persistently non-eosinophilic differ in their benefit from inhaled corticosteroid treatment compared to patients who are not persistently non-eosinophilic.

Timeline

Start
2014-07
Primary completion
2018-05
Completion
2018-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone Other / unclassified 220 ug Inhaled
Subject Tiotropium Other / unclassified 5 ug

Indications